Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 340

1.

Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.

Haidry RJ, Lipman G, Banks MR, Butt MA, Sehgal V, Graham D, Dunn JM, Gupta A, Sweis R, Miah H, Morris D, Smart HL, Bhandari P, Willert R, Fullarton G, Morris J, Di Pietro M, Gordon C, Penman I, Barr H, Patel P, Boger P, Kapoor N, Mahon B, Hoare J, Narayanasamy R, O'Toole D, Cheong E, Direkze NC, Ang Y, Veitch A, Dhar A, Nyalender D, Ragunath K, Leahy A, Fullard M, Rodriguez-Justo M, Novelli M, Lovat LB.

Endoscopy. 2015 Nov;47(11):980-7. doi: 10.1055/s-0034-1392414. Epub 2015 Jun 30.

PMID:
26126159
2.

Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.

Chennat J, Konda VJ, Ross AS, de Tejada AH, Noffsinger A, Hart J, Lin S, Ferguson MK, Posner MC, Waxman I.

Am J Gastroenterol. 2009 Nov;104(11):2684-92. doi: 10.1038/ajg.2009.465. Epub 2009 Aug 18.

PMID:
19690526
3.

Eliminating a need for esophagectomy: endoscopic treatment of Barrett esophagus with early esophageal neoplasia.

Lada MJ, Watson TJ, Shakoor A, Nieman DR, Han M, Tschoner A, Peyre CG, Jones CE, Peters JH.

Semin Thorac Cardiovasc Surg. 2014 Winter;26(4):274-84. doi: 10.1053/j.semtcvs.2014.12.004. Epub 2014 Dec 24.

PMID:
25837538
4.

Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.

Larghi A, Lightdale CJ, Ross AS, Fedi P, Hart J, Rotterdam H, Noffsinger A, Memeo L, Bhagat G, Waxman I.

Endoscopy. 2007 Dec;39(12):1086-91. Epub 2007 Aug 15.

PMID:
17701854
5.

Radiofrequency ablation for Barrett's-associated intramucosal carcinoma: a multi-center follow-up study.

Strauss AC, Agoston AT, Dulai PS, Srivastava A, Rothstein RI.

Surg Endosc. 2014 Dec;28(12):3366-72. doi: 10.1007/s00464-014-3629-0.

PMID:
24950726
6.

Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.

Chennat J, Ross AS, Konda VJ, Lin S, Noffsinger A, Hart J, Waxman I.

Gastrointest Endosc. 2009 Sep;70(3):417-21. doi: 10.1016/j.gie.2009.01.047. Epub 2009 Jun 24.

PMID:
19555948
7.

Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry.

Haidry RJ, Dunn JM, Butt MA, Burnell MG, Gupta A, Green S, Miah H, Smart HL, Bhandari P, Smith LA, Willert R, Fullarton G, Morris J, Di Pietro M, Gordon C, Penman I, Barr H, Patel P, Boger P, Kapoor N, Mahon B, Hoare J, Narayanasamy R, O'Toole D, Cheong E, Direkze NC, Ang Y, Novelli M, Banks MR, Lovat LB.

Gastroenterology. 2013 Jul;145(1):87-95. doi: 10.1053/j.gastro.2013.03.045. Epub 2013 Mar 28.

PMID:
23542069
8.

Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia.

Kim HP, Bulsiewicz WJ, Cotton CC, Dellon ES, Spacek MB, Chen X, Madanick RD, Pasricha S, Shaheen NJ.

Gastrointest Endosc. 2012 Oct;76(4):733-9. doi: 10.1016/j.gie.2012.04.459. Epub 2012 Jun 23.

9.

Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry.

Haidry RJ, Butt MA, Dunn JM, Gupta A, Lipman G, Smart HL, Bhandari P, Smith L, Willert R, Fullarton G, Di Pietro M, Gordon C, Penman I, Barr H, Patel P, Kapoor N, Hoare J, Narayanasamy R, Ang Y, Veitch A, Ragunath K, Novelli M, Lovat LB; UK RFA Registry.

Gut. 2015 Aug;64(8):1192-9. doi: 10.1136/gutjnl-2014-308501. Epub 2014 Dec 24.

10.

Endoscopic mucosal resection results in change of histologic diagnosis in Barrett's esophagus patients with visible and flat neoplasia: a multicenter cohort study.

Wani S, Abrams J, Edmundowicz SA, Gaddam S, Hovis CE, Green D, Gupta N, Higbee A, Bansal A, Rastogi A, Early D, Lightdale CJ, Sharma P.

Dig Dis Sci. 2013 Jun;58(6):1703-9. doi: 10.1007/s10620-013-2689-7. Epub 2013 Apr 30.

11.

Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.

Neuhaus H, Terheggen G, Rutz EM, Vieth M, Schumacher B.

Endoscopy. 2012 Dec;44(12):1105-13. doi: 10.1055/s-0032-1310155. Epub 2012 Sep 11.

PMID:
22968641
12.

Endoscopic treatment of Barrett's esophagus: From metaplasia to intramucosal carcinoma.

Chennat J, Waxman I.

World J Gastroenterol. 2010 Aug 14;16(30):3780-5. Review.

13.

Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study.

van Vilsteren FG, Alvarez Herrero L, Pouw RE, Visser M, Ten Kate FJ, van Berge Henegouwen MI, Schoon EJ, Weusten BL, Bergman JJ.

Endoscopy. 2012 Dec;44(12):1096-104. doi: 10.1055/s-0032-1325731. Epub 2012 Oct 29.

PMID:
23108809
14.

Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.

van Vilsteren FG, Alvarez Herrero L, Pouw RE, Schrijnders D, Sondermeijer CM, Bisschops R, Esteban JM, Meining A, Neuhaus H, Parra-Blanco A, Pech O, Ragunath K, Rembacken B, Schenk BE, Visser M, ten Kate FJ, Meijer SL, Reitsma JB, Weusten BL, Schoon EJ, Bergman JJ.

Endoscopy. 2013 Jul;45(7):516-25. doi: 10.1055/s-0032-1326423. Epub 2013 Apr 11.

PMID:
23580412
15.

The impact of endoscopic ultrasound findings on clinical decision making in Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.

Bulsiewicz WJ, Dellon ES, Rogers AJ, Pasricha S, Madanick RD, Grimm IS, Shaheen NJ.

Dis Esophagus. 2014 Jul;27(5):409-17. doi: 10.1111/j.1442-2050.2012.01408.x. Epub 2012 Sep 27.

16.

Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how?

Konda VJ, Ferguson MK.

World J Gastroenterol. 2010 Aug 14;16(30):3786-92. Review.

17.

Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus.

Small AJ, Sutherland SE, Hightower JS, Guarner-Argente C, Furth EE, Kochman ML, Forde KA, Bewtra M, Falk GW, Ginsberg GG.

Gastrointest Endosc. 2015 May;81(5):1158-66.e1-4. doi: 10.1016/j.gie.2014.10.029. Epub 2015 Jan 31.

PMID:
25650071
18.

Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.

Thota PN, Arora Z, Dumot JA, Falk G, Benjamin T, Goldblum J, Jang S, Lopez R, Vargo JJ.

Dig Dis Sci. 2018 May;63(5):1311-1319. doi: 10.1007/s10620-018-5009-4. Epub 2018 Mar 9.

PMID:
29524114
19.

Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial.

van Vilsteren FG, Pouw RE, Seewald S, Alvarez Herrero L, Sondermeijer CM, Visser M, Ten Kate FJ, Yu Kim Teng KC, Soehendra N, Rösch T, Weusten BL, Bergman JJ.

Gut. 2011 Jun;60(6):765-73. doi: 10.1136/gut.2010.229310. Epub 2011 Jan 5.

PMID:
21209124
20.

Salvage cryotherapy after failed radiofrequency ablation for Barrett's esophagus-related dysplasia is safe and effective.

Sengupta N, Ketwaroo GA, Bak DM, Kedar V, Chuttani R, Berzin TM, Sawhney MS, Pleskow DK.

Gastrointest Endosc. 2015 Sep;82(3):443-8. doi: 10.1016/j.gie.2015.01.033. Epub 2015 Apr 14.

PMID:
25887715

Supplemental Content

Support Center